Nrx Pharmaceuticals, INC. (NRXPW) — DEFA14A Filings

All DEFA14A filings from Nrx Pharmaceuticals, INC.. Browse 3 DEFA14A reports with AI-powered summaries and risk analysis.

DEFA14A Filings (3)

NRX Pharmaceuticals Files Proxy Statement — Mar 20, 2024 Risk: low
NRX Pharmaceuticals, Inc. filed a Definitive Proxy Statement (DEFA14A) on March 20, 2024. This filing relates to the company's proxy materials, which are typica
NRX Pharma Files Proxy Statement for Share Distribution — Mar 18, 2024 Risk: medium
NRX Pharmaceuticals, Inc. (NRXP) filed a DEFA14A, indicating it is a definitive proxy statement. The filing relates to the company's plan to distribute shares o
NRX Pharmaceuticals Files Proxy Statement — Mar 13, 2024 Risk: low
NRX Pharmaceuticals, Inc. filed a Definitive Proxy Statement (DEFA14A) on March 13, 2024. This filing is related to the company's proxy materials, which are typ

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX